Mitochondrial diseases from children to adults (CARAMMEL)

French national reference center for mitochondrial diseases from children to adults (CARAMMEL)

Logo Carammel

The reference center for « mitochondrial diseases from children to adults » (CARAMMEL), located in the  Necker-Enfants malades university hospital, coordinates the national CARAMMEL network, which is made up of 4 constitutive centers (Angers, Bordeaux, Strasbourg, Le Kremlin-Bicêtre) and 4 competence centers (Rouen, Caen, Créteil-Henri Mondor, Paris Lariboisière) dedicated to the diagnosis and treatment of patients with mitochondrial diseases.

The members of the Necker reference center are clinical and molecular geneticists, paediatricians, neuropaediatricians, adult neurologists, metabolists, radiologists, biochemists and researchers. The diversity of the professions represented reflects the extreme variety of clinical manifestations of mitochondriopathies which involve all medical specialities. The members of the reference center meet on a weekly basis in order to assess the files of patients seen during a consultation or hospitalisation at Necker, or files submitted to them by colleagues outside Necker.

This clinical activity feeds a high-level clinical and fundamental research activity.

This reference center is affiliated to the Filnemus rare disease healthcare network and to the EURO-NMD european reference network (ERN).

> Visit the national Carammel website

Keywords : Mitochondrial disease, mitochondrial myopathy, cardiomyopathy, ataxia, Leigh syndrome, respiratory chain, optic atrophy, mitochondrial DNA.

Information Coronavirus Carammel

Logo filnemusLogo Euro-NMD

Medical
team

Manuel Schiff MaMea

Head of the reference center
Pr Manuel Schiff
MD, PhD

Contact us
 

Talk to someone or make an appointment

Phone +33 1 44 49 51 64
or + 33 1 44 49 51 64
or + 33 1 44 49 51 53

> Send an email

> Send an email to the secretariat of the reference center

In case of emergency

appel urgence Carammel english
  1. Expertise mission
    • Development of recommendations or care protocols to promote good practices in patient care
    • Dissemination and implementation of recommendations, protocols and procedures within the FILNEMUS healthcare network
    • Participation in national and international working groups
    • Coordination of a weekly multidisciplinary consultation meeting (RCP) in person and remotely with the participation of other reference centers of the CARAMMEL network
    • Validation of indications for high-throughput sequencing for mitochondrial diseases in the SeqOIA platform
  2. Recourse mission
    • Medical consultations, teleconsultations, hospitalizations
    • Advice on files, local or remote
    • Diagnosis announcement
    • Off-label prescriptions and orphan drugs
    • Postnatal, prenatal and preimplantation diagnostic tests
  3. Research and epidemiological surveillance mission
    • Implementation of and participation in national and international funded research projects
    • Dissemination of knowledge through :
      • publications in national or international peer-reviewed journals
      • communications in national or international conferences
    • Evaluation of the recourse activity from a quantitative and qualitative point of view
    • Participation in the collection of data in national or international databases
  4. Education and training mission
    • Teaching medical, undergraduate and graduate students
    • Training within the framework of continuous professional development (CPD)
    • Hosting of students in connection with the « Genetics of mitochondrial diseases » research team of the IMAGINE university hospital institute at Necker in the framework of M1, M2, university, medical and pharmaceutical theses
    • Writing of articles and books with educational content
Manuel Schiff MaMea

Pediatrician
Pr Jean-Paul Bonnefont
MD, PhD

Arnold Munnich Carammel

Pediatrician-Geneticist
Pr Arnold Munnich
MD, PhD

Benoit Funalot Carammel

Geneticist and adult neurologist
Pr Benoit Funalot
MD, PhD

Pascale de Lonlay MaMea

Pediatrician
Pr Pascale de Lonlay
MD, PhD

Nathalie Boddaert Carammel

Radiologist
Pr Nathalie Boddaert
MD, PhD

Agnes Rötig Carammel

Research director
Dr Agnès Rötig
PhD

Giulia Barcia Carammel

Geneticist and neuropediatrician
Dr Giulia Barcia
MD, PhD

Manuel Schiff MaMea

Metabolic pediatrician
Pr Manuel Schiff
MD, PhD

Isabelle Desguerre Maladies neuromusculaires

Neuropediatrician
Pr Isabelle Desguerre
MD, PhD

photo-identite-femme magec2

Pediatrician
Dr Claire-Marine Dufeu-Berat
MD

Julie Steffann Carammel

Geneticist
Pr Julie Steffann
MD, PhD

 

Neuropediatrician
Pr Pierre Landrieu
MD, PhD

photo-identite-femme magec2

Biologist
Zahra Assouline
PhD

 

Insofar as the natural history of mitochondrial diseases differs from one patient to another, and/or organ damage is associated in a non-systematic way, the structuring of therapeutic education is based on multidisciplinary skills for each child and at each moment.
The permanence of care is ensured by the site’s coordinating physician, or one of his assistants, who calls on organ specialists on a case-by-case basis depending on the clinical manifestations.
The child-adult transition is crucial: it is necessary to develop a network of referents in the different adult specialties.

As an example, a weekly genetic consultation has been developed at Necker, which is essentially a children’s hospital, and is provided by an adult neurogeneticist. He is responsible for referring patients leaving the pediatric age group to the various adult specialists.

  • EJP-RD –  Genomit 3, Mitochondrial Disorders: from a global registry to medical genomics, toward clinical trials – Imagine Institute, UMR1163 – in progress
  • AFM – Deficient protein processing in mitochondrial diseases – Imagine Institute, UMR1163 – in progress
  • Dillon Foundation – Design of an AAV-based gene therapy for mitochondrial disease caused by mutations in the RNA stability factor LRPPRC – Imagine Institute, UMR1163 – in progress
  • DIM Thérapie génique – Thérapie génique de l’ataxie de Friedreich – Imagine Institute, UMR1163 – in progress
  • DIM Thérapie génique – Gene therapy approach to treat mitochondrial diseases caused by defects in mitochondrial gene expression – Imagine Institute, UMR1163 – in progress
  • Crosslab Institut Imagine – ImmunoMito – Defects of mitochondrial DNA maintenance and dysregulated immune response – Imagine Institute, UMR1163 – in progress
  • MSD Avenir – Devo-Decode project – Decoding developmental disorders in humans – Imagine Institute, UMR1163 – in progress
  • E-rare – Genomit 2, Mitochondrial Disorders: from a world-wide registry to medical genomics, toward molecular mechanisms and new therapies – Imagine Institute, UMR1163 – finalized
  • AFAF – Homéostasie du fer dans des modèles cellulaires d’ataxie de Friedreich – Imagine Institute, UMR1163 – finalized
  • AFM – An integrated approach for mitochondrial disorder therapeutics: from yeasts and worms to humans – Imagine Institute, UMR1163 – finalized
  • Fondation Maladies Rares – Imagine Institute, UMR1163 – finalized
  • AFM Mitochondrial replacement therapy against mtDNA disorders. Are we far from its clinical application? – Imagine Institute, UMR1163 – in progress

2021

2020

2019

2018

2017

2016

PARTICIPATION IN SCIENTIFIC EVENTS

ORAL COMMUNICATIONS AT INTERNATIONAL CONFERENCES

  • Agnès Rötig. Leigh syndrome, Experience in France. ENMC workshop on “Genetic Epidemiology and Clinical Trial Readiness in Encephalomyopathy of Leigh Syndrome”, 16 Octobre et 20 Décembre 2020, 9 Juillet 2021.
  • Agnès Rötig. Abnormal regulation of transferrin receptor in NBIA. 7 th International Symposium on NBIA and related disorders, 1-3 Octobre 2020, on line.
  • Julie Steffann: “PGD for mtDNA disorders; success and challenge. The French experience”. Taskforce on « Nuclear Transfer for mitochondrial diseases and infertility 2021 Gent Belgium
  • Julie Steffann: Developping guidelines for management of reproductive options for families with maternally inherited mtDNA disease.  ENMC Leigh  2021  Amsterdam
  • Julie Steffann: “PGD for mitochondrial DNA disorder: feasibility and concerns”.  The 5th World Congress on Controversies in preconception, preimplantation, and prenatal genetic diagnosis (CoGEN) Paris 2020

Contact information

Necker-Enfants malades university Hospital
> Genomic medicine of rare diseases department
Molecular genetics laboratory

149 rue de Sèvres
75743 PARIS Cedex 15

> Pediatric welcome booklet
> Adult patients welcome booklet

In Necker, the reference center for mitochondrial diseases from children to adults (CARAMMEL) in brief …

0
patients followed at least once a year*
0
medical consultations*
0
day hospitalizations*
0
fully hospitalized patients*
0
patients trained in therapeutic education*
0
teleconsultation procedures*
0
ongoing research projects*
0
university courses*
0
publications*

* data valid for 2022